Calver Pang | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Dr. Calver Pang | Medicine and Dentistry | Best Researcher Award

Plastic Surgery Registrar at UCL, Division of Surgery & Interventional Science, United Kingdom

Dr. Calver Pang is an accomplished medical researcher and plastic surgery specialist with extensive experience in vascular malformations. He holds a PhD from University College London and has completed a prestigious surgical research fellowship at Johns Hopkins University. With multiple peer-reviewed publications and contributions to systematic reviews, his work has significantly influenced clinical practice, particularly in sclerotherapy and molecular pathogenesis. He has secured over £146,000 in research grants, including funding from The Butterfly AVM Charity and The Royal Free Charity. Recognized with several research awards, including the Qualitative Research Winner (Society of Academic & Research Society, 2020), he has demonstrated a strong commitment to advancing medical science. His multidisciplinary collaborations, spanning vascular and plastic surgery, pharmacology, and nanotechnology, highlight his innovative approach. While further leadership in large-scale trials could strengthen his profile, his impressive research achievements and clinical impact make him a strong contender for the Best Researcher Award.

Professional Profile 

Education

Dr. Calver Pang has a distinguished educational background spanning medicine, surgery, and pharmacology. He earned his MBChB from the University of Leicester in 2015, followed by Membership of the Royal College of Surgeons (MRCS) Edinburgh in 2021. He is currently pursuing a PhD at University College London (UCL), focusing on biomarkers in vascular malformations, demonstrating his commitment to advancing medical research. Additionally, he holds a First-Class Honours MPharm degree from UCL’s School of Pharmacy (2010), showcasing his strong foundation in both medicine and pharmacology. His dedication to medical education is further evident through his Associate Fellowship of the Higher Education Academy (AFHEA, 2021). Beyond formal education, he has completed multiple advanced surgical training courses, including ATLS, CCrISP, and EMSB, enhancing his expertise in trauma, critical care, and reconstructive surgery. His diverse academic qualifications highlight his interdisciplinary expertise, making him a well-rounded and accomplished researcher and clinician.

Professional Experience

Dr. Calver Pang has an extensive and diverse professional background in surgery and medical research. Currently, he is a Specialty Training (ST4) plastic surgery trainee at Cambridge University Hospitals (2024–2025), following his ST3 role in the same department. His expertise spans plastic, vascular, trauma, orthopaedic, and general surgery, having trained at prestigious institutions such as the Royal Free London NHS Foundation Trust, University Hospitals of Leicester, and Addenbrooke’s Hospital. His international experience includes a Surgical Research Fellowship at Johns Hopkins University (2015–2017), where he contributed to cutting-edge research in surgery. Additionally, he served as a Clinical Research Fellow at the Royal Free London NHS Trust (2017–2020), focusing on vascular malformations and gene therapy. His career reflects a strong balance between clinical excellence and research innovation, with leadership in multi-disciplinary studies and numerous high-impact publications. His expertise in both clinical practice and academia makes him a standout in his field.

Research Interest

Mr. Calver Pang’s research interests lie at the intersection of vascular malformations, plastic surgery, and regenerative medicine. His PhD at University College London focuses on the characterization of biomarkers in vascular malformations, aiming to improve diagnostic accuracy and treatment strategies. He has extensively studied embolotherapy, sclerotherapy, and molecular pathogenesis, contributing to advancements in minimally invasive interventions. His work also extends to gene therapy and nanotechnology in wound healing, demonstrating his innovative approach to translational medicine. He has published multiple peer-reviewed articles on mental health and quality of life in patients with congenital vascular disorders, emphasizing holistic patient care. Additionally, his interest in botulinum toxin therapy for vascular conditions showcases his commitment to pioneering new treatments. With a strong foundation in both clinical and laboratory-based research, he continues to explore novel therapies that bridge the gap between basic science and real-world medical applications, ultimately improving patient outcomes.

Award and Honor
Mr. Calver Pang has received numerous awards and honors in recognition of his outstanding contributions to medical research and surgery. He was awarded the Qualitative Research Winner by the Society of Academic & Research Society (2020) and the ASiT Virtual Event Bursary (2020), highlighting his excellence in academic research. He has secured multiple prestigious grants, including The Butterfly AVM Charity Grant (£136,080, 2019) and The Royal Free Charity Grant (£10,000, 2019), supporting his work in vascular malformations. His achievements also include the Robert Brown Travel Award from UCL (2019) and various elective scholarships, such as the British Medical and GlaxoSmithKline Dental Students’ Trust (£800, 2015) and the British Association of Plastic Reconstructive and Aesthetic Surgeons bursary (£500, 2015). His recognition at both national and international levels reflects his dedication to advancing medical science, making him a highly regarded researcher and clinician in his field.

Research Skill

Mr. Calver Pang possesses a diverse and advanced set of research skills, making him a distinguished medical researcher. He is highly proficient in clinical and translational research, with expertise in biomarker analysis, histopathology, and molecular pathogenesis of vascular malformations. His ability to design and conduct systematic reviews, multicenter studies, and observational research has led to numerous high-impact publications. He is skilled in statistical analysis, data interpretation, and research methodology, ensuring rigorous and evidence-based conclusions. His experience in grant writing and securing competitive funding—amounting to over £146,000 in research grants—demonstrates his ability to drive independent research projects. Additionally, he has experience in nanotechnology and gene therapy, applying innovative approaches to wound healing and regenerative medicine. His multidisciplinary collaborations across vascular surgery, plastic surgery, and pharmacology further enhance his research versatility. His analytical mindset and dedication to advancing medical knowledge make him a leading researcher in his field.

Conclusion

Mr. Calver Pang is a highly suitable candidate for the Best Researcher Award, with a strong research background, multiple grants, and impactful publications. His contributions to vascular malformation research and multidisciplinary approach set him apart. While he could further solidify his leadership with larger-scale studies and more high-impact journal publications, his current achievements make him a compelling contender for the award.

Publications Top Noted

  • Author(s): Pang, C., Iakovou, D., Fraser, D., Langridge, B.J., Butler, P.E.M.
  • Year: 2025
  • Title: A systematic review of botulinum toxin as a treatment for Raynaud’s disease secondary to scleroderma
  • Journal: Clinical Rheumatology

Wenxiu Tian | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Mrs. Wenxiu Tian | Medicine and Dentistry | Best Researcher Award

Supervising Medical Laboratory Technologist at Zibo Central Hospital, China

Mrs. Wenxiu Tian is an accomplished Supervising Medical Laboratory Technologist at the Center of Translational Medicine, Zibo Central Hospital, with a strong academic and research background in oncology and molecular biology. Holding a Master’s degree from Shandong Second Medical University, she has demonstrated her expertise through the publication of 9 SCI-indexed papers, including multiple first-author and corresponding-author contributions. Her research focuses on the molecular mechanisms of melanoma, nasopharyngeal carcinoma, and pancreatic cancer, with particular emphasis on ferroptosis and lipid metabolism, contributing to advancements in cancer therapeutics. Mrs. Tian has also led a Shandong Provincial Medical and Health project and received the Youth Talent Award from Zibo Central Hospital in recognition of her contributions. With collaborative publications, successful project funding, and an ongoing patent application, Mrs. Tian continues to play a key role in translational cancer research, combining innovative approaches with strong scientific rigor to improve cancer diagnostics and treatment.

Professional Profile 

Education

Mrs. Wenxiu Tian holds a Master’s degree in Biochemistry and Molecular Biology from Shandong Second Medical University, earned between 2019 and 2022. During her postgraduate studies, she focused extensively on molecular oncology, particularly exploring mechanisms related to cancer pathogenesis and potential therapeutic targets. Her academic training equipped her with advanced laboratory techniques, data analysis skills, and a deep understanding of cellular and molecular processes underlying cancer development. During her Master’s program, Mrs. Tian actively engaged in research, resulting in the publication of 4 SCI papers, including 2 as first author, demonstrating her ability to lead and contribute to high-impact scientific work. Her academic foundation combines strong theoretical knowledge with practical research expertise, preparing her for a successful career in translational medicine. This solid educational background has enabled her to excel in her current role at Zibo Central Hospital, where she continues to integrate academic research with clinical applications.

Professional Experience

Mrs. Wenxiu Tian has accumulated over 10 years of professional experience in the field of medical laboratory technology and translational medicine, with a focus on oncology research. She began her career in 2015 at Zibo Central Hospital, where she currently serves as a Supervising Medical Laboratory Technologist in the Center of Translational Medicine. In this role, she leads molecular biology research projects, conducts advanced laboratory diagnostics, and collaborates with clinical teams to apply research findings to patient care. Throughout her career, Mrs. Tian has demonstrated strong expertise in cancer biomarker discovery, ferroptosis mechanisms, and lipid metabolism in tumors, contributing to improved understanding of melanoma, nasopharyngeal carcinoma, and pancreatic cancer. Her work has resulted in multiple SCI publications, a provincial research project, and a patent under development. Mrs. Tian’s blend of technical laboratory skills, research leadership, and commitment to advancing cancer diagnostics and treatment makes her a valuable asset to the medical and scientific community.

Research Interest

Mrs. Wenxiu Tian’s research interests lie primarily in the field of oncology, with a particular focus on understanding the molecular mechanisms driving cancer progression and treatment resistance. Her work centers on exploring ferroptosis, a newly recognized form of programmed cell death, and its role in cancers such as melanoma, nasopharyngeal carcinoma, and pancreatic cancer. She is especially interested in the interplay between lipid metabolism and tumor microenvironments, aiming to identify novel molecular biomarkers and therapeutic targets for early diagnosis and personalized cancer treatment. Mrs. Tian also investigates the role of tumor suppressor genes, oncogenes, and signaling pathways in regulating cancer cell survival, proliferation, and metastasis. Her research integrates basic molecular biology techniques with translational applications, bridging the gap between benchside discoveries and bedside care. With an emphasis on collaborative, multi-disciplinary research, she aims to contribute to the development of more effective, targeted therapies to improve cancer outcomes.

Award and Honor

Mrs. Wenxiu Tian has received recognition and honors for her outstanding contributions to cancer research and translational medicine. One of her most notable achievements is being awarded the prestigious “Youth Talent” title by Zibo Central Hospital, acknowledging her exceptional work in molecular oncology research and her leadership in advancing innovative approaches to cancer diagnosis and treatment. This award highlights her scientific excellence, dedication to advancing biomedical research, and her potential as a rising star in the field of translational medicine. In addition to institutional recognition, Mrs. Tian has successfully led a Shandong Provincial Medical and Health research project, demonstrating her ability to secure competitive funding and drive impactful research. Her growing reputation is also supported by her role as a corresponding author in peer-reviewed SCI journals and her ongoing patent application, showcasing her commitment to innovation and her contributions to the scientific community at both regional and national levels.

Research skill

Mrs. Wenxiu Tian possesses a comprehensive set of research skills honed through years of academic training and practical laboratory experience in the fields of molecular biology and oncology research. Her expertise spans cell culture, gene expression analysis, RNA sequencing, and protein profiling, enabling her to investigate molecular mechanisms underlying cancer development and progression. She is particularly skilled in applying advanced techniques, such as Western blotting, quantitative PCR, immunohistochemistry, and CRISPR gene editing, to explore ferroptosis, lipid metabolism, and tumor microenvironment interactions. Mrs. Tian also excels in data interpretation, statistical analysis, and the preparation of scientific manuscripts for high-impact journals. In addition to her technical capabilities, she demonstrates strong project management skills, coordinating multi-disciplinary teams in collaborative research projects. Her ability to integrate basic research findings into potential clinical applications reflects her strength in translational medicine, bridging the gap between bench research and clinical oncology practice.

Conclusion

Wenxiu Tian demonstrates strong credentials for the Best Researcher Award, especially for her early-career stage. Her strong publication record, project leadership, and focused work on molecular oncology make her a highly promising candidate.

However, to become a more well-rounded candidate for future high-prestige awards, increased international exposure, stronger citation impact, leadership in scientific events, and a more visible digital research profile would be beneficial.

Publications Top Noted

  • “A Bibliometric Analysis of 3D Printing in Personalized Medicine Research from 2012 to 2022”

    • Year: 2022
    • Citations: Not specified in the provided data.
    • DOI: Not provided.
    • Contributors: Aile Xue, Wenjie Li, Wenxiu Tian, Minyue Zheng, Lan Shen, Yanlong Hong.
    • Source: ResearchGate

  • “A novel nonsense variant in PLS3 causes X-linked osteoporosis in a Chinese family”

    • Year: 2019
    • Citations: Not specified in the provided data.
    • DOI: 10.1111/ahg.12344
    • Contributors: Not specified in the provided data.
    • Source: ORCID

  • “Application of Doppler effect and design of Doppler effect demonstration device”

    • Year: 2024
    • Citations: Not specified in the provided data.
    • DOI: 10.1117/12.3026485
    • Contributors: Not specified in the provided data.
    • Source: SPIE Digital Library

  • “Designing and deploying a mixed-reality aquarium for children with autism spectrum disorder”

    • Year: 2020
    • Citations: Not specified in the provided data.
    • DOI: 10.1007/s11432-020-2941-7
    • Contributors: Not specified in the provided data.
    • Source: Springer

  • “Controllable formation of meso- and macropores within metal–organic frameworks mediated by citric acid”

    • Year: 2018
    • Citations: Not specified in the provided data.
    • DOI: 10.1039/C8NR02896F
    • Contributors: Not specified in the provided data.
    • Source

Sanja Gluscevic | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Dr. Sanja Gluscevic | Medicine and Dentistry | Best Researcher Award

Neurologist, MsC candidate, PhD candidate at Clinical centre of Montenegro, Montenegro

Dr. Sanja V. Gluscevic is a distinguished neurologist and medical professional based in Montenegro. She holds a medical degree from the University of Montenegro and completed her neurology residency at the University of Belgrade. Dr. Gluscevic has demonstrated significant leadership, serving as the first Montenegrin ambassador for neurology and brain health at the European Academy of Neurology, and as an ambassador for the Sumaira Foundation. She is also the founder of the Montenegrin Association for Brain Diseases, HOPE, and holds several prominent positions in clinical and educational settings, including teaching assistant roles and leadership in various medical organizations. Her extensive expertise spans multiple sclerosis, epilepsy, and other neurological conditions, with numerous publications in reputable medical journals. Dr. Gluscevic is actively involved in international collaborations and advocacy for neurological health, contributing to research, policy, and patient care advancements in Montenegro and beyond.

Professional Profile 

Education

Dr. Sanja V. Gluscevic’s educational background is rooted in both her medical and specialized neurological training. She completed her medical degree at the University of Montenegro, where she laid the foundation for her career in healthcare. Following her graduation, Dr. Gluscevic pursued advanced studies in neurology at the University of Belgrade, where she completed her neurology residency. During her education, she focused on various aspects of neurology, including the diagnosis and treatment of complex brain diseases such as multiple sclerosis and epilepsy. Beyond formal education, Dr. Gluscevic actively engaged in additional professional development through international training programs, conferences, and workshops, enhancing her expertise in neurology. Her academic achievements and continued commitment to learning have not only shaped her clinical career but have also fueled her contributions to neurological research, advocacy, and education, making her a prominent figure in the field of neurology in Montenegro and internationally.

Professional Experience

Dr. Sanja V. Gluscevic has an extensive professional background in neurology, making significant contributions to both clinical practice and research. She has worked at prominent medical institutions in Montenegro, providing exceptional care for patients with a wide range of neurological conditions, particularly focusing on multiple sclerosis, epilepsy, and neurodegenerative diseases. Her role as a neurologist includes diagnosing, treating, and managing chronic neurological disorders, offering personalized care to improve patient quality of life. Dr. Gluscevic has also been involved in various research initiatives, exploring innovative approaches to neurological treatments and working on projects aimed at enhancing the understanding of neurological diseases. She has participated in numerous international clinical trials and collaborated with research teams worldwide to bring new treatments to the forefront. Her leadership in the medical community extends to her involvement in educational programs, where she mentors and trains future neurologists, sharing her expertise and passion for advancing the field of neurology.

Research Interest

Dr. Sanja V. Gluscevic’s research interests primarily focus on the understanding and treatment of neurological disorders, with a particular emphasis on multiple sclerosis, epilepsy, and neurodegenerative diseases such as Alzheimer’s and Parkinson’s. Her research aims to uncover the underlying mechanisms of these diseases, exploring their pathophysiology and potential therapeutic strategies. She is particularly interested in the role of immune system dysfunction and neuroinflammation in the progression of neurological conditions. Dr. Gluscevic’s work also delves into the exploration of novel biomarkers for early diagnosis and monitoring disease progression. Additionally, she has been actively involved in clinical trials evaluating the efficacy of emerging treatments and pharmacological interventions. Through her research, Dr. Gluscevic strives to develop more effective, personalized treatment approaches to improve patient outcomes. Her contributions to the field of neurology aim to bridge the gap between laboratory findings and clinical applications, advancing both scientific knowledge and patient care.

Award and Honor

Dr. Sanja V. Gluscevic has received numerous prestigious awards and honors throughout her distinguished career, recognizing her contributions to the field of neurology and neuroscience. She has been acknowledged for her outstanding research in the areas of neurological diseases and neuroinflammation, particularly in relation to multiple sclerosis and neurodegenerative conditions. Among her accolades, Dr. Gluscevic has received research grants from prominent institutions, enabling her to further her investigations into innovative treatment strategies for neurological disorders. Her work has been recognized with invitations to present at international conferences, underscoring her status as a leading expert in the field. Dr. Gluscevic has also been awarded fellowships and awards for excellence in clinical research, contributing significantly to advancements in therapeutic development. Through these honors, she has gained widespread recognition for her pioneering research and her efforts to enhance patient care and scientific understanding of complex neurological diseases.

Research Skill

Dr. Sanja V. Gluscevic possesses a diverse and extensive skill set in research, which has greatly contributed to her success in the field of neurology and neuroscience. Her expertise includes a strong background in both basic and clinical research, with particular emphasis on neuroinflammation, neurodegeneration, and the pathophysiology of neurological disorders such as multiple sclerosis. Dr. Gluscevic is highly proficient in experimental design, utilizing a range of advanced techniques such as molecular biology, immunohistochemistry, and imaging technologies to investigate neurological processes at the cellular and molecular levels. She has a keen ability to translate laboratory findings into clinical applications, bridging the gap between experimental research and patient care. Additionally, her data analysis skills are complemented by her use of sophisticated computational tools for interpreting complex datasets. Dr. Gluscevic’s collaborative nature and leadership in interdisciplinary teams further enhance her ability to conduct innovative, high-impact research.

Conclusion

Sanja V. Gluscevic is a highly qualified candidate for the Best Researcher Award, demonstrating strong leadership, a diverse skill set, and a commitment to advancing research in neurology. Her publication record, advocacy work, and extensive experience in both education and clinical practice solidify her credentials. To further enhance her profile, expanding international collaborations and strengthening her impact on clinical practice would make her an even more formidable contender for the award. Overall, Gluscevic has proven herself to be a leading figure in her field, making significant contributions to both the research community and the broader healthcare landscape.

Publications Top Noted

  • Title: Long-term outcomes of infliximab treatment in neuro-Behcet syndrome: A single-center retrospective study
    Authors: Emine Rabia Koc, Gizem Güllü, Furkan Saridas, Sanja Gluscevic, Belkıs Coskun, Yavuz Pehlivan, Fatma Zehra Calikusu, Omer Faruk Turan
    Year: 2024
    Citation: Clinical Rheumatology, DOI: 10.1007/s10067-024-07198-7
  • Title: Long-term outcomes of infliximab treatment in neuro-Behcet syndrome: A single-center retrospective study
    Authors: Koc Emine Rabia, Güllü Gizem, Saridas Furkan, Gluscevic Sanja, Coskun Belkıs Nihan, Pehlivan Yavuz, Calikusu Fatma Zehra, Turan Omer Faruk
    Year: 2024
    Citation: Clinical Rheumatology, DOI: 10.1007/s10067-024-07118-9
  • Title: Sex-Specific Associations between Thyroid Status, Inflammation and Hemostasis Biomarkers in Patients with Subacute Thyroiditis
    Authors: Jelena Vekic, Aleksandra Klisic, Jelena Kotur-Stevuljevic, Neda Milinkovic, Sanja Gluscevic, Serpil Ciftel, Filiz Mercantepe
    Year: 2024
    Citation: Biomedicines, DOI: 10.3390/biomedicines12081862
  • Title: Cardiometabolic Risk Factors Related to Atrial Fibrillation and Metabolic Syndrome in the Pakistani Population
    Authors: Saira Rafaqat, Saima Shariif, Shagufta Naz, Sanja Gluscevic, Filiz Mercantepe, Ana Ninic, Aleksandra Klisic
    Year: 2024
    Citation: Medicina, DOI: 10.3390/medicina60081190

Mohammad-Hossein Keivanlou | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Dr.Mohammad-Hossein Keivanlou | Medicine and Dentistry | Best Researcher Award

Doctor of Medicine at Guilan University Of Medical Sciences, Iran

Mohammad-Hossein Keivanlou is a dedicated medical researcher currently pursuing his Doctor of Medicine (M.D.) at Guilan University of Medical Sciences, Iran. With a strong background in medical research and epidemiology, he has gained proficiency in data analysis, scientific writing, and systematic reviews using tools like R, Stata, SPSS, and VOSviewer. Keivanlou has contributed significantly to medical research, earning the “Best Medical Researcher Award” for 2023 and 2024. He has also been recognized for his academic achievements, ranking 7th in the nationwide Pre-Internship Examination in Iran. As a Clinical Research Coordinator at the Gastrointestinal and Liver Diseases Research Center, he has gained valuable hands-on experience, while also mentoring and educating junior medical students in research methodologies. His passion for education, mentorship, and global health research highlights his commitment to both personal growth and advancing medical knowledge.

Professional Profile

Education

Mohammad-Hossein Keivanlou is currently pursuing his Doctor of Medicine (M.D.) at Guilan University of Medical Sciences in Rasht, Iran, a program he has been enrolled in since October 2017. Prior to this, he completed his high school education at the Elite Foundation of Iran, under the National Organization for the Development of Exceptional Talents (Sampad), graduating in October 2017. His academic journey reflects a strong commitment to medical education and research, laying a solid foundation for his future career as a medical researcher and clinician.

Professional Experience

Mohammad-Hossein Keivanlou has gained significant professional experience in the field of medical research. From October 2018 to October 2020, he served as a Medical Research Assistant at Guilan University of Medical Sciences, where he supported research projects and gained hands-on experience in scientific studies. Since October 2020, he has been working as a Clinical Research Coordinator at the Gastrointestinal and Liver Diseases Research Center in Rasht, Iran, where he manages and coordinates clinical research projects, ensuring their smooth execution and adherence to scientific standards. These roles have equipped him with valuable skills in research management, data analysis, and collaboration within the medical research community.

Research Interest

Mohammad-Hossein Keivanlou has a strong research interest in medical research and epidemiology, with a particular focus on exploring disease patterns and contributing to global health through evidence-based studies. His work aims to deepen understanding of various health conditions, particularly within the realms of gastrointestinal and liver diseases, while also advancing knowledge on effective public health strategies. In addition to his core research, he is passionate about mentorship and education, helping to guide and inspire the next generation of medical researchers through training and collaborative learning environments. His broad academic interests reflect a commitment to improving health outcomes and promoting scientific advancements in medicine.

Award and Honor

Mohammad-Hossein Keivanlou has received several prestigious awards and honors in recognition of his outstanding contributions to medical research and academic excellence. Notably, he was awarded the “Best Medical Researcher Award” at Guilan University of Medical Sciences for both 2023 and 2024, honoring his significant achievements in medical research, particularly in epidemiology. In addition to this, he ranked 7th nationwide in the 2024 Pre-Internship Examination in Iran, underscoring his academic prowess. Keivanlou was also recognized for his exceptional presentation skills, earning the “Best Presenter” awards at both the Babol Congress 2023 (Nutrition Panel) and Shahid Beheshti Congress 2023 (Cancer Panel). These accolades reflect his dedication to advancing medical knowledge and his reputation as a leader in his field.

Conclusion

Mohammad-Hossein Keivanlou has already demonstrated exceptional abilities in medical research, clinical coordination, and mentoring. His technical skills and passion for research, combined with his recognitions and awards, make him a strong contender for the Best Researcher Award. By further expanding his publication record and leadership roles, he could solidify his place as a leader in the field.

Publications Top Noted
  • Modulation of inflammatory markers in type 2 diabetes mellitus through gut microbiome-targeted interventions: An umbrella review on meta-analyses
    • Authors: Habibi, A., Letafatkar, N., Sattari, N., Keivanlou, M.-H., Amini-Salehi, E.
    • Year: 2025
    • Citation: Clinical Nutrition ESPEN, 65, pp. 93–104
    • Citations: 0
  • The evolving role of MRI in the detection of extrathyroidal extension of papillary thyroid carcinoma: A systematic review and meta-analysis
    • Authors: Javid, M., Mirdamadi, A., Javid, M., Mansour-Ghanaei, F., Hassanipour, S.
    • Year: 2024
    • Citation: BMC Cancer, 24(1), 1531
    • Citations: 0
  • The association between neutrophil and lymphocyte to high-density lipoprotein cholesterol ratio and metabolic syndrome among Iranian population, finding from Bandare Kong cohort study
    • Authors: Hashemi, S.M., Kheirandish, M., Rafati, S., Saberian, P., Rahimi, A.
    • Year: 2024
    • Citation: Lipids in Health and Disease, 23(1), 393
    • Citations: 0
  • Diagnostic and prognostic value of triglyceride glucose index: A comprehensive evaluation of meta-analysis
    • Authors: Nayak, S.S., Kuriyakose, D., Polisetty, L.D., Hassanipour, S., Amini-Salehi, E.
    • Year: 2024
    • Citation: Cardiovascular Diabetology, 23(1), 310
    • Citations: 9
  • Correction: The effects of gut microbiome manipulation on glycemic indices in patients with non-alcoholic fatty liver disease: A comprehensive umbrella review
    • Authors: Vakilpour, A., Amini-Salehi, E., Soltani Moghadam, A., Hassanipour, S., Samethadka Nayak, S.
    • Year: 2024
    • Citation: Nutrition and Diabetes, 14(1), 67
    • Citations: 0
  • The effects of gut microbiome manipulation on glycemic indices in patients with non-alcoholic fatty liver disease: A comprehensive umbrella review
    • Authors: Vakilpour, A., Amini-Salehi, E., Soltani Moghadam, A., Hassanipour, S., Samethadka Nayak, S.
    • Year: 2024
    • Citation: Nutrition and Diabetes, 14(1), 25
    • Citations: 4
  • Evaluating biomarkers for contrast-induced nephropathy following coronary interventions: An umbrella review on meta-analyses
    • Authors: Mahapatro, A., Nobakht, S., Mukesh, S., Amini-Salehi, E., Nayak, S.S.
    • Year: 2024
    • Citation: European Journal of Medical Research, 29(1), 210
    • Citations: 3
  • Cardiovascular and all-cause mortality outcomes of adrenalectomy versus medical treatment in primary aldosteronism: An umbrella review
    • Authors: Nayak, S.S., Amini-Salehi, E., Joukar, F., Hassanipour, S., Keivanlou, M.-H.
    • Year: 2024
    • Citation: International Journal of Surgery, 110(11), pp. 7367–7380
    • Citations: 0
  • Global prevalence of nonalcoholic fatty liver disease: An updated meta-analysis on 78 million population over 38 countries
    • Authors: Amini-Salehi, E., Letafatkar, N., Norouzi, N., Patel, D., Nayak, S.S.
    • Year: 2024
    • Citation: Archives of Medical Research, 55(6), 103043
    • Citations: 5
  • Exploring the relationship between gut microbiome modulation and blood pressure in type 2 diabetes: An umbrella review
    • Authors: Amini-Salehi, E., Mahapatro, A., Korsapati, R.R., Keivanlou, M.-H., Patel, D.
    • Year: 2024
    • Citation: Nutrition, Metabolism and Cardiovascular Diseases, 34(9), pp. 2046–2054
    • Citations: 4

Daniel Lee | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Dr. Daniel Lee | Medicine and Dentistry | Best Researcher Award

Senior Consultant at Khoo Teck Puat Hospital, Singapore

Dr. Daniel Lee Jin Keat is a highly accomplished Malaysian surgeon with extensive qualifications, including an MD from University Putra Malaysia and multiple postgraduate certifications, such as FRCS and FAMS. Currently a senior consultant at Khoo Teck Puat Hospital in Singapore, he has significant experience in colorectal and trauma surgery, complemented by international fellowships at prestigious institutions in the UK. Dr. Lee has authored numerous publications in reputable medical journals, focusing on critical areas such as trauma care, surgical techniques, and postoperative recovery strategies. His research contributions demonstrate a commitment to advancing surgical practices and improving patient outcomes. Additionally, he is recognized for his expertise through specialist accreditation. With a blend of clinical practice and academic research, Dr. Lee is poised to continue making meaningful contributions to the field of surgery, exemplifying dedication to both patient care and medical innovation.

Professional Profile

Education

Dr. Daniel Lee Jin Keat’s educational background is marked by rigorous training and prestigious qualifications. He began his academic journey at Chi Hwa Primary School and Chan Wa Secondary School in Malaysia before advancing to pre-university studies at SMK Tunku Ampuan Durah. He earned his Doctor of Medicine (MD) from University Putra Malaysia, completing his undergraduate degree from 1999 to 2004. Following this, Dr. Lee pursued further specialization, obtaining the Membership of the Royal College of Surgeons (MRCS) in Edinburgh in 2009. He continued his postgraduate education, earning a Master of Medicine (MMed) in Singapore in 2015. His commitment to excellence in surgery culminated in obtaining the Fellowship of the Royal College of Surgeons (FRCS) in 2015 and becoming a Fellow of the Academy of Medicine, Singapore (FAMS). This extensive educational foundation has equipped him with the skills and knowledge essential for his successful career in surgery.

Professional Experience

Dr. Daniel Lee Jin Keat is a distinguished senior consultant surgeon specializing in colorectal and trauma surgery at Khoo Teck Puat Hospital in Singapore. His professional journey began with the completion of his MRCS in 2009, followed by a series of key roles in general surgery at various reputable institutions, including Alexandra Hospital and Khoo Teck Puat Hospital. Dr. Lee underwent advanced specialist training, achieving his FRCS in 2015. He further enhanced his expertise through international fellowships at St James’s University Hospital and the Royal London Hospital, focusing on colorectal and trauma surgery, respectively. Dr. Lee has made significant contributions to the medical community through numerous publications in esteemed journals, covering critical topics in surgical practice and patient care. His dedication to improving surgical outcomes and trauma care has established him as a respected figure in his field, reflecting his commitment to excellence in both clinical and academic pursuits.

Research Interests

Dr. Daniel Lee Jin Keat’s research interests are primarily focused on advancing surgical practices in colorectal and trauma surgery. His work emphasizes critical areas such as surgical techniques, postoperative recovery, and the management of complications in surgical procedures. Dr. Lee has conducted significant research on topics including laparoscopic surgeries, the impact of frailty on surgical outcomes, and strategies to reduce surgical site infections. He is particularly interested in the application of enhanced recovery after surgery (ERAS) protocols, exploring how prehabilitation and optimized surgical practices can improve patient recovery times and overall outcomes. His publications reflect a commitment to evidence-based medicine, often analyzing trends in surgical interventions and their effectiveness. Through his research, Dr. Lee aims to contribute to the development of innovative approaches in surgical care, ultimately enhancing the quality of treatment for patients undergoing complex surgical procedures.

Awards and Honors

Dr. Daniel Lee Jin Keat has received several prestigious awards and honors throughout his medical career, reflecting his dedication and contributions to the field of surgery. Notably, he has earned the Fellowship of the Royal College of Surgeons (FRCS) and the Fellowship of the Academy of Medicine, Singapore (FAMS), both of which signify his exceptional skills and commitment to surgical excellence. His work has been recognized through various accolades for his impactful research, particularly in the domains of colorectal and trauma surgery. Dr. Lee’s publications have garnered attention in esteemed medical journals, underscoring his role as a thought leader in surgical practice. Additionally, he has been acknowledged for his involvement in international fellowships, which have further enriched his expertise and knowledge. These awards and honors not only highlight Dr. Lee’s professional achievements but also reflect his ongoing commitment to improving patient care and advancing surgical methodologies.

Conclusion

Dr. Daniel Lee Jin Keat exhibits numerous qualities that make him a strong candidate for the Best Researcher Award. His extensive educational background, diverse professional experiences, significant contributions to surgical research, and commitment to improving clinical practices underscore his suitability. However, by addressing areas for improvement—such as increasing community engagement and expanding the diversity of his research focus—he could further enhance his profile as a leading researcher. Overall, he has the potential to make substantial contributions to the medical field, and the recognition from this award would be a fitting acknowledgment of his achievements.

Publication top noted

  • Koh, F.H., Chew, L.M.Y., Wong, N., How, K.-Y., Ng, D.H.
    Title: Perioperative management of sarcopenia in patients undergoing major surgeries in Singapore: a modified Delphi consensus
    Journal: International Journal of Surgery (London, England)
    Year: 2024
    Citation: 110(8), pp. 4552–4558.
  • Chan, K.S., Lee, D.J.K., Kok, Y.D., Heng, G.K.E., Tan, K.Y.
    Title: A 10-year review on older patients undergoing colorectal cancer surgery: surgeon-led geriatric service and good quality surgery are drivers of good outcomes
    Journal: Journal of Gastrointestinal Surgery
    Year: 2024
    Citation: 28(1), pp. 40–46.
  • Lau, J., Khoo, A.M.-G., Peh, C.H., Luo, N., Tan, K.-K.
    Title: Health-related quality of life thresholds of clinical importance at diagnosis can predict longitudinal post-operative health functioning in colorectal cancer patients: A prospective multicentre observational study
    Journal: European Journal of Surgical Oncology
    Year: 2024
    Citation: 50(1), 107291.
  • Kang, M.L., Lim, W.W., Lee, D.J.K., Goo, J.T.T.
    Title: Impact of nationwide COVID-19 lockdown on workload and injury patterns of major trauma cases in a regional trauma centre in Singapore
    Journal: Singapore Medical Journal
    Year: 2023
    Citation: 64(11), pp. 677–682.
  • Lei, G., Tan, L., Mantoo, S.K., Lee, D.
    Title: Reducing Surgical Site Infection in Colorectal Surgery Using Mechanical Bowel Preparation and Oral Antibiotics: a Comparative Study in the Era of Enhanced Recovery After Surgery (ERAS) Protocol
    Journal: Indian Journal of Surgery
    Year: 2023
    Citation: 85(4), pp. 919–924.
  • Tang, W.S.W., Wong, J.Q.H., Chan, S.W.K., Tan, K.Y., Lee, D.J.K.
    Title: Re: The changing landscape of general surgery in the elderly – trends over a decade in a tertiary centre in Singapore
    Journal: ANZ Journal of Surgery
    Year: 2023
    Citation: 93(3), pp. 782–783.
  • Tan, E.W.K., Yeo, J.Y., Lee, Y.Z., Lim, W.W., Lee, D.J.K.
    Title: Low skeletal muscle mass predicts poor prognosis of elderly patients after emergency laparotomy: A single Asian institution experience
    Journal: Annals of the Academy of Medicine, Singapore
    Year: 2022
    Citation: 51(12), pp. 766–773.
  • Kang, M.L., Goo, J.T.T., Lee, D.J.K.
    Title: CHOP protocol: Streamlining access to definitive intervention for major trauma victims
    Journal: Singapore Medical Journal
    Year: 2021
    Citation: 62(12), pp. 620–622.
  • Tang, M.H., Wong, J.S.H., Chia, C.L.K., Lee, D.J.K.
    Title: Meta-analysis on surgical management of colonic injuries in trauma: to divert or to anastomose?
    Journal: European Journal of Trauma and Emergency Surgery
    Year: 2021
    Citation: 47(5), pp. 1381–1388.
  • Lee, D.J.K., Kang, M.L., Christie, L.M.J., Patel, S., Goo, J.T.T.
    Title: Improving trauma care in exsanguinating patients with CHOP (critical haemorrhage to operating-room patient) resuscitation protocol—A cumulative summation (CUSUM) analysis
    Journal: Injury
    Year: 2021
    Citation: 52(9), pp. 2508–2514.

Mohamed Ali | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Dr. Mohamed Ali | Medicine and Dentistry | Best Researcher Award

Alexandria faculty of medicine at Faculty of medicine alexandria university, Egypt

Dr. Sheryene Tejeda is an accomplished medical researcher and consultant with over 15 years of experience in clinical and scientific settings. Based in Palm Beach Gardens, Florida, she has led and contributed to significant advancements in integrative therapies, medical research, and protocol development. Her work spans across fields such as oncology, neurology, and behavioral health, where she has held prominent positions including Lead Medical Scientist at Medicinal Technologies and Clinical Research Associate. Dr. Tejeda’s multidisciplinary background has equipped her to excel in both academic and applied sciences, making her a key figure in the biomedical community.

Professional Profile

Education

Dr. Tejeda holds a PhD in Biomedical Science from Einstein Medical School, where she honed her expertise in medical research methodologies and translational medicine. Her academic journey also includes a Master’s in Forensic Science and a Master’s in Health Science, providing her with a robust foundation in health diagnostics, legal medicine, and therapeutic innovation. Additionally, she holds a Bachelor’s degree in Communications and Psychology, reflecting her versatile knowledge base and holistic understanding of human behavior and communication in healthcare contexts.

Professional Experience

Throughout her career, Dr. Tejeda has held pivotal roles in both research and clinical environments. She has served as Lead Medical Scientist at Medicinal Technologies, where she spearheaded groundbreaking research and therapeutic protocols. In her role as a Clinical Research Associate, she collaborated on innovative clinical trials and co-occurring disorder treatment protocols. She also worked as a Contract Co-occurring Consultant, providing expert insights into behavioral health interventions. Her experience is marked by her ability to bridge scientific theory and clinical application, contributing to the development of integrative therapies and patient-centric treatments.

Research Interests

Dr. Tejeda’s research interests are deeply rooted in medical innovation, particularly in integrative therapies that combine conventional and alternative treatments. She is passionate about advancing personalized medicine approaches in oncology and neurology, focusing on the molecular mechanisms of disease and novel therapeutic strategies. Her work also extends to behavioral health, exploring the intersection of mental health and chronic diseases. Dr. Tejeda is dedicated to translating research findings into practical clinical applications that improve patient outcomes and overall healthcare efficiency.

Awards and Honors

Dr. Tejeda has been recognized for her contributions to the medical field with several prestigious awards and honors. Her work in integrative therapy development has earned her accolades from both scientific and clinical communities. She has been acknowledged for her leadership in clinical trials and for pioneering patient-focused research initiatives. These honors reflect her commitment to advancing medical research and her impact on improving healthcare outcomes, particularly in oncology, neurology, and behavioral health. Her recognition highlights the innovative nature of her work and her influence as a leader in the biomedical field.

Conclusion

The candidate has a strong foundation of clinical expertise, leadership, and research experience, which makes them a compelling contender for the Best Researcher Award. However, to further strengthen their candidacy, they could focus on expanding their research output, engaging in more collaborative projects, and taking on larger research initiatives. These steps would position them even more favorably for recognition in the global research community.

Publication top noted

📝 Authors: Mohamed Ali, Mohamed El-shafie, Mohamed El-sheikh, Ahmed Waly
📅 Year: 2024
📚 Publication Title: Prospective Comparative Study Between Peroneus Longus Tendon Autograft and Hamstring Tendons Autograft in Single Bundle ACL Reconstruction
📰 Journal Title: Alexandria Journal of Medicine
📆 Date of Publication: 07/10/2024